title: Use of crystal methamphetamine among gay men in London.
abstract: OBJECTIVE
  To examine the use of crystal methamphetamine (crystal meth) and its association with high-risk sexual behaviour among gay men in London.
  
  
  METHODS
  Cross-sectional surveys using self-administered questionnaires.
  
  
  METHODS
  National Health Service (NHS) out-patient human immunodeficiency virus (HIV) treatment clinic in London; NHS HIV testing/sexual health clinics in London; central London gyms.
  
  
  METHODS
  HIV-positive gay men attending the HIV treatment clinic in 2002-03 (n = 388); HIV-negative gay men attending the HIV testing/sexual health clinics in 2002-03 (n = 266); gay men using the gyms between January and March 2003 (n = 445), 2004 (n = 653) and 2005 (n = 494).
  
  
  METHODS
  Percentage of gay men who reported: (i) using crystal meth in the previous 12 months; (ii) using other recreational drugs (e.g. cocaine, ecstasy, ketamine); (iii) high-risk sexual behaviour in the previous 3 months.
  
  
  RESULTS
  The percentage of gay men who had used crystal meth in the previous year varied by sample (HIV treatment clinic, 12.6%; HIV testing/sexual health clinics, 8.3%; gyms, 19.5%; P < 0.001) but did not change over time in the gyms (19.8%, 20.7%, 17.8%; P = 0.5). In all samples, the majority of men used crystal meth only once or twice a year. Most crystal meth users (> 80%) had taken other recreational drugs. Crystal meth and other drug users were more likely to report high-risk sexual behaviour than other men, e.g. HIV treatment clinic sample: crystal meth users, 34.7%; other drug users, 18.9%, non-users, 10.6%, P < 0.001. Cause and effect could not be established.
  
  
  CONCLUSIONS
  Among gay men in London surveyed in clinics, approximately one in 10 reported using crystal meth in the previous 12 months (HIV-positive men 12.6%; HIV-negative men 8.3%). Most men used it infrequently--only once or twice a year. There was no evidence of increasing use of crystal meth between 2003 and 2005.
authors.affiliation: City University, London, UK, MRC Social and Public Health Sciences Unit, Glasgow, UK.
authors.forename: Graham
authors.initials: G
authors.lastname: Bolding
authors.forename: Graham
authors.initials: G
authors.lastname: Hart
authors.forename: Lorraine
authors.initials: L
authors.lastname: Sherr
authors.forename: Jonathan
authors.initials: J
authors.lastname: Elford
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology*; D000328:Adult; D019969:Amphetamine-Related Disorders / Q000453:epidemiology*; D003430:Cross-Sectional Studies; D006213:Hallucinogens; D018451:Homosexuality, Male / Q000706:statistics & numerical data*; D006801:Humans; D013287:Illicit Drugs; D008131:London; D008297:Male; D008694:Methamphetamine; D047568:Unsafe Sex / Q000706:statistics & numerical data*
chemical_list: D006213:Hallucinogens; D013287:Illicit Drugs; D008694:Methamphetamine